Pallavi Mangesh Patil

Pallavi Mangesh Patil

Auto-generated profile, based on publicly available information

Pallavi Mangesh Patil

Department of Pharmaceutical Chemistry, Modern College of Pharmacy, Affiliated to Savitribai Phule Pune University, Pune, India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Journal of Pharmacy Research
Verified
Journal Article
Closed access
PPPallavi Mangesh Patil
Pallavi Mangesh Patil
SWSagar Baliram Wankhede
Sagar Baliram Wankhede
PCPraveen Digambar Chaudhari
Praveen Digambar Chaudhari

1 December 2014 in Bulletin of Faculty of Pharmacy, Cairo University
Verified
Journal Article
Open access
PPPallavi M. Patil
Pallavi M. Patil
SWSagar B. Wankhede
Sagar B. Wankhede
PCPraveen D. Chaudhari
Praveen D. Chaudhari
A sensitive stability indicating high-performance thin-layer chromatographic method was developed and validated for quantitative determination of Acyclovir in tablets. Chromatographic separation was performed on a precoated silica gel 60F254 HPTLC plates using Toluene: n-Butanol: Methanol: Water (5.0:3.0:1.0:1.0 v/v/v/v) as a mobile phase. A TLC scanner set at 259nm was used for direct evaluation of the chromatograms in reflectance/absorbance mode. Acyclovir and degradant were satisfactorily resolved with Rf values of 0.62±0.05, 0.78±0.05, respectively. Calibration curve was a polynomial in the concentration range of 200–1000ng/band. The high correlation coefficient (r2>0.9991) values indicated clear correlations between the investigated compound concentrations and their peak areas within the test ranges. The method was validated according to ICH guidelines. The repeatability and intermediate precision, expressed by the RSD, were less than 2.0%. The accuracy and validity of the method were further ascertained by performing recovery studies via a standard addition method. The accuracy of the method expressed as percent recovery was satisfactory (99.85%). The drug was subjected to the International Conference on Harmonization (ICH)-prescribed hydrolytic, oxidative, photolytic and thermal stress conditions. The method was validated according to ICH guidelines. The drug showed instability in alkaline and oxide while it remained stable in heat and UV radiation conditions. The proposed HPTLC method was utilized to investigate the alkaline degradation of Acyclovir (ACY). The performance of the method was validated according to the present ICH guidelines for specificity, limit of detection, limit of quantification, linearity, accuracy, precision, ruggedness and robustness

5 January 2021 in Journal of Chromatographic Science
Verified
Journal Article
Closed access
SKShivani Kalokhe
Shivani Kalokhe
SNSantaji Nalwade
Santaji Nalwade
PPPallavi Patil
Pallavi Patil
PRPoonam Raskar
Poonam Raskar
A novel, delicate, stability-indicating, gradient, reversed-phase high-performance liquid chromatographic method has been established for the quantitative estimation of methocarbamol (MTC) and its impurities present in a pharmaceutical oral suspension. XBridge C18, 5 μm, 250 mm × 4.6 mm column was used to accomplish chromatographic separation with a buffered mobile phase consisting of a mixture of 0.01 M of sodium dihydrogen phosphate (pH 7.0 buffer) and methanol in the ratio of 95:05 (v/v), respectively, were used as solvent A and a mixture of methanol and Milli-Q water in the ratio 90:10 (v/v), respectively, was used as solvent B. Analysis was carried out at 0.8 mL/min flow rate and the detection wavelength at 225 nm. The compartment temperature of the column is put at 25°C. The resolution of MTC and its four impurities has been attained >2.0 for all pairs of compounds. Significant degradation of MTC was photolytic, thermal and oxidative stress conditions. Validation of the developed method was performed as stated by the International Conference on Harmonization guidelines with regard to all validation parameters like specificity, accuracy, linearity, precision, limit of detection, limit of quantitation and robustness.

3 September 2017 in Analytical Chemistry Letters
Verified
Journal Article
Closed access
PPPallavi M. Patil
Pallavi M. Patil
SWSharad Wawdhane
Sharad Wawdhane
PCPraveen Chaudhari
Praveen Chaudhari
The stability of Rivaroxaban (RIVA) drug was determined under different stress conditions in accordance with International Conference on Harmonization (ICH) guidelines Q1A (R2). The chromatogram was developed on precoated silica gel 60F254 TLC plates using ethyl acetate: acetonitrile (5:5 v/v) as a mobile phase. There was no chromatographic interference from the tablet excipients and compact spots were observed for RIVA (Rf = 0.28 ± 0.05). When studied under varied stress conditions, the drug was found susceptible for degradation under acidic and oxide stress conditions. However, it was stable under neutral, thermal and photolytic stress conditions. In total, two degradation products (DPs) were formed. IR and MS/TOF with NMR studies were conducted on a mixture of stressed samples to obtain functional group and mass spectral data. The study data from precise mass study was initially used to pattern a complete mass fragmentation pathway of the drug and later for its degradation products. Considering the best possible molecular formula, structures were suggested for each fragment. Two novel degradation products namely, (R-4-(4-(5-(Aminomethyl)-2-Oxooxazolidin-3-yl) phenyl-Morpholin-3-One HCl and (R-4-(4-(5-(dioxymethyl)-2-Oxooxazolidin-3-yl) phenyl-Morpholin-3-One were identified.

3 May 2016 in Analytical Chemistry Letters
Verified
Journal Article
Closed access
PPPallavi Patil
Pallavi Patil
SWS. B. Wankhede
S. B. Wankhede
PCPraveen Chaudhari
Praveen Chaudhari
The current study reports the characterization of degradation product from Ritonavir (RITO) through mass spectrometry and the development of a validated and stability-indicating High performance thin layer chromatographic method for the determination of RITO in the presence of its process-related degradation in bulk drug. Stability study on Ritonavir (RITO) was carried out under hydrolytic condition in acidic, alkaline and peroxide, thermal and photolytic conditions in accordance with International Conference on Harmonization (ICH) guidelines Q1 (R2). The drug was found susceptible for degradation under acidic conditions while in rest of conditions drug were stable. A degradation product (DP) was formed in acidic condition. Chromatographic separation was performed on precoated silica gel 60F254 HPTLC plates using acetonitrile: methanol: water (5:3.5:2.5 v/v) as a mobile phase. A mixture of stressed samples was subjected for IR and MS/TOF studies to obtain functional group and mass spectral data. The data found from precise mass study was first utilized to pattern a complete mass fragmentation pathway of the drug and later it was used for its degradant. Structures were proposed for each fragments based on best possible molecular formula. Acidic degradation of RITO 3((3S, 4R)-3-isopropyl-4-(((S)-2-((methoxycarbonyl) amino)-3-phenylpropyl) amino)-2-oxo-5-phenylpentyl)-1-((2isopropylthiazol-4-yl) methyl)-1-methyluronium was identified.

22 November 2025 in Discover Chemistry
Verified
Journal Article
Open access
PDF file
SBSanket Bora
Sanket Bora
PPPallavi Patil
Pallavi Patil
MCMahavir Chhajed
Mahavir Chhajed
MTMohamad Taleuzzaman
Mohamad Taleuzzaman
Non-small cell lung cancer (NSCLC) remains the most prevalent and fatal subtype of lung cancer, with resistance to current EGFR inhibitors posing a major therapeutic challenge. In this study, a novel series of chromone–benzothiazole hybrids ( 4a–4d ) was designed, synthesized, and evaluated as potential EGFR-targeting anticancer agents. The Knoevenagel condensation method enabled efficient one-pot synthesis using L-proline as a green catalyst. All compounds were characterized by FT-IR, NMR, and HRMS. Molecular docking against EGFR (PDB ID: 3W2O) showed superior binding affinities compared to Erlotinib and 5-FU, with 4d exhibiting the strongest interaction (–8.2 kcal/mol) via π–π stacking and π–sulfur interactions. In silico ADMET analysis predicted good absorption, low CNS permeability, moderate clearance, and acceptable toxicity profiles. In vitro cytotoxicity (MTT assay on A549 lung cancer cells) revealed dose-dependent anti-proliferative effects, with 4d showing the highest efficacy (IC₅₀ = 40.53 µg/mL), closely comparable to 5-fluorouracil (IC₅₀ = 38.12 µg/mL). Structure–activity relationship (SAR) analysis indicated that para-substituted electron-withdrawing groups enhance EGFR affinity, while hydroxyl and methoxy groups improve pharmacokinetics. Overall, 4d emerged as a promising lead for further development as a targeted EGFR inhibitor for NSCLC therapy. Graphical Abstract